The Latest Breaking News from EMERGENT

Sam Bankman-Fried was ordered to forfeit $11 billion in assets after he was found guilty of fraud and other related charges late last year, and now three separate groups are claiming all or some of the assets linked to the collapse of the FTX crypto empire.

There is hope in the news that the leading version of naloxone, the No. 1 drug used to reverse opioid overdoses, will soon be available without a prescription. Making it easier to obtain the life-saving drug should save lives, but the devil, as they say, may be in the details.

BALTIMORE — Joined by harm-reduction advocates, local musicians performed outside a Baltimore drug manufacturing facility Wednesday afternoon to protest the price of the overdose-reversing drug Narcan sold by pharmaceutical company Emergent BioSolutions.

BALTIMORE — The tally of wasted COVID-19 vaccine continues to climb at the troubled Emergent BioSolutions plant in East Baltimore and now exceeds a half billion doses, according to findings a congressional panel released Thursday on the manufacturer once central to the U.S. coronavirus pandemic response.

Here's a roundup of top developments in the biotech space over the last 24 hours:

Reuters

Johnson & Johnson (NYSE: JNJ) has made another move towards severing its Covid-19 vaccine manufacturing ties with contract manufacturer Emergent Biosolutions, Inc. (NYSE: EBS).

Emergent BioSolutions Inc (NYSE: EBS) said Johnson & Johnson (NYSE: JNJ) had breached an agreement by failing to buy the company's minimum quantity of COVID-19 vaccines.

Emergent BioSolutions Inc (NYSE:EBS) has agreed to acquire Chimerix Inc's (NASDAQ:CMRX) exclusive worldwide rights to Tembexa (brincidofovir), the first FDA-approved antiviral for all age groups for smallpox.  "It exemplifies our thoughtful M&A strategy as part of our 2024 growth plan and positions us better to deliver value for our shareholders," said Robert Kramer, president…